Early hypocoagulable state in traumatic brain injury patients: incidence, predisposing factors, and outcomes in a retrospective cohort study
Sina Zoghi,Ali Ansari,Tej D. Azad,Amin Niakan,Seyed Amin Kouhpayeh,Reza Taheri,Hosseinali Khalili
DOI: https://doi.org/10.1007/s10143-024-02523-9
IF: 2.8
2024-06-27
Neurosurgical Review
Abstract:Coagulopathy development in traumatic brain injury (TBI) is among the significant complications that can negatively affect the clinical course and outcome of TBI patients. Timely identification of this complication is of utmost importance in the acute clinical setting. We reviewed TBI patients admitted to our trauma center from 2015 to 2021. Demographic data, mechanism of injury, findings on admission, imaging studies, procedures during hospitalization, and functional outcomes were gathered. INR with a cutoff of 1.3, platelet count less than 100 × 109/L, or partial thromboplastin time greater than 40s were utilized as the markers of coagulopathy. A total of 4002 patients were included. Coagulopathy occurred in 38.1% of the patients. Age of the patients (Odds Ratio (OR) = 0.993, 95% Confidence Interval (CI) = 0.986–0.999, p = 0.028), systolic blood pressure (OR = 0.993, 95% CI = 0.989–0.998, p = 0.005), fibrinogen level (OR = 0.998, 95% CI = 0.996–0.999, p < 0.001), and hemoglobin level (OR = 0.886, 95% CI = 0.839–0.936, p < 0.001) were independently associated with coagulopathy. Furthermore, coagulopathy was independently associated with higher mortality rates and longer ICU stays. Coagulopathy had the most substantial effect on mortality of TBI patients (OR = 2.6, 95% CI = 2.1–3.3, p < 0.001), compared to other admission clinical characteristics independently associated with mortality such as fixed pupillary light reflex (OR = 1.8, 95% CI = 1.5–2.4, p < 0.001), GCS (OR = 0.91, 95% CI = 0.88–0.94, p < 0.001), and hemoglobin level (OR = 0.93, 95% CI = 0.88–0.98, p = 0.004). Early coagulopathy in TBI patients can lead to higher mortality rates. Future studies are needed to prove that early detection and correction of coagulopathy and modifiable risk factors may help improve outcomes of TBI patients.
surgery,clinical neurology